Recommended Covid-19 vaccinations will remain free in Switzerland in 2023, including for residents and cross-border workers not subject to compulsory health insurance, according to government measures adopted on Friday.
“Vaccination is a central element in the fight against the pandemic, offering good protection against severe forms of the disease and preventing hospitalisation,” said the Federal Council in a press releaseExternal link.
It also decided to continue to sell unused vaccine doses to other countries in 2023. According to this strategy adopted in February 2022, a maximum of 13 million doses in the year can be sold or transferred if they are not used in Switzerland.
The Alpine country has already donated millions of doses and some have expired because of a supply glut. It announced in February, for example, that it would donate up to 15 million shots in the first half of 2022 to the COVAX initiative for equitable vaccine distribution.
A new wave of coronavirus infections and hospital admissions emerged in Switzerland in September; numbers have since stabilised at a high level. A total of 16,362 new Covid cases were reported on December 13 for the previous seven-day period, down 12% on the previous week. Health officials nonetheless say there are a high number of unreported new infections.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
Too many Covid doses: Switzerland’s vaccine conundrum
This content was published on
Switzerland is sitting on around 38 million excess Covid-19 vaccine doses to be used by the end of 2022. What will it do with them?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.